BriaCell Therapeutics (BCTX) shares plummeted more than 40% in recent trading on Tuesday after the company priced a $5 million offering of common shares and warrants.
The company said it priced the offering of about 5.12 million shares and warrants to buy roughly 5.12 million shares at $0.975 per share and associated warrant.
Warrants in the offering can be exercised for $0.85 to purchase one share of the company immediately after issuance and expire after five years, BriaCell added.
The company said it expects to close the offering on Wednesday and use the proceeds from the offering for working capital requirements, general corporate purposes, and advance business objectives.
Price: 0.74, Change: -0.50, Percent Change: -40.08
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。